Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      FORMOTEROL; ADRENERGIC beta agonists; DRUG therapy for asthma; ANTIASTHMATIC agents; PHYSIOLOGY; THERAPEUTICS
    • Abstract:
      Interpretation: When taken as needed, formoterol 4.5 mg provided better asthma control than terbutaline 0.5 mg in patients requiring moderate doses of relief medication despite inhaled corticosteroid treatment. Safety studies should be extended to a wider population of patients with asthma. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)